Illumina abandons $1.2 bln deal to buy rival Pacific Biosciences
January 02, 2020 at 16:41 PM EST
Illumina Inc on Thursday agreed to terminate the $1.2 billion deal to buy smaller rival Pacific Biosciences of California Inc, weeks after the U.S. competition watchdog filed a complaint to block the purchase.